Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diseases of the Thyroid
  Free Subscription

Articles published in
J Endocrinol Invest
    August 2025
  1. HAI Y, Ma Q, Huang A, Fang S, et al
    Bibliometrics in thyroid eye disease.
    J Endocrinol Invest. 2025 Aug 29. doi: 10.1007/s40618-025-02688.
    >> Share

  2. CARRILLO JF, Carrillo LC, Serrano-Arevalo ML, Perez-Baez WB, et al
    Prognostic role of the BRAF V600E variant in the preoperative biopsy in differentiated thyroid cancer.
    J Endocrinol Invest. 2025 Aug 23. doi: 10.1007/s40618-025-02694.
    >> Share

  3. GATTA E, Maltese V, Ugoccioni M, Silvestrini I, et al
    Could thyrotropin serum level characterize major depressive disorder phenotype? A systematic review and meta-analysis.
    J Endocrinol Invest. 2025 Aug 19. doi: 10.1007/s40618-025-02687.
    >> Share

  4. MARINO PICCIOLA V, Zatelli MC, Sena LM
    Art, diet and thyroid disease: interpreting the goiter motif in the trivulzio tapestries.
    J Endocrinol Invest. 2025 Aug 12. doi: 10.1007/s40618-025-02685.
    >> Share

  5. PAN LH, Yeh CC, Yang SJ, Yang CC, et al
    A Prospective Study to Determine Trimester-Specific Thyroid Function Reference Intervals.
    J Endocrinol Invest. 2025 Aug 11. doi: 10.1007/s40618-025-02651.
    >> Share

  6. LI X, Zhao H, Xiao Z
    Effects of sphingolipid metabolism related genes-SPTLC1, ORMDL3, SPHK1 and S1PR3 polymorphisms on susceptibility to hashimoto's thyroiditis.
    J Endocrinol Invest. 2025 Aug 9. doi: 10.1007/s40618-025-02666.
    >> Share

  7. PALADINO ME, Riva MA
    The goitrous sponge-bearer in Francesco Bianchi Ferrari's Pala delle Tre Croci (c. 1495).
    J Endocrinol Invest. 2025 Aug 7. doi: 10.1007/s40618-025-02681.
    >> Share

  8. BARTALENA L, Gallo D, Kahaly GJ, Piantanida E, et al
    Process to radioactive iodine treatment for Graves' hyperthyroidism: condemned or absolved?
    J Endocrinol Invest. 2025 Aug 6. doi: 10.1007/s40618-025-02653.
    >> Share

  9. YANG W, Xu X, Xie R, Lin J, et al
    Tryptophan metabolites exert potential therapeutic activity in graves' orbitopathy by ameliorating orbital fibroblasts inflammation and proliferation.
    J Endocrinol Invest. 2025;48:1781-1795.
    >> Share

  10. MARTIN A, Fernandez MC, Miraglia S, Venara M, et al
    Brachyury and IGF1R: potential opposing roles in pediatric thyroid nodular pathology.
    J Endocrinol Invest. 2025 Aug 1. doi: 10.1007/s40618-025-02667.
    >> Share

    July 2025
  11. HONKANEN J, Molnar K, Karhumaa T, Kakko S, et al
    Patients undergoing thyroid surgery suffer preoperatively from poor quality of life.
    J Endocrinol Invest. 2025 Jul 29. doi: 10.1007/s40618-025-02661.
    >> Share

  12. CASIRAGHI A, Cattoni A, Persani L
    Update on diagnostic and therapeutic challenges of central hypothyroidism among childhood cancer survivors.
    J Endocrinol Invest. 2025 Jul 28. doi: 10.1007/s40618-025-02659.
    >> Share

  13. WANG L, Cao J, Tian J, Zhang H, et al
    Characteristic volume, texture, and functional connectivity alterations in hypothalamic subunits of adult primary hypothyroidism: a multiparametric MRI analysis.
    J Endocrinol Invest. 2025 Jul 24. doi: 10.1007/s40618-025-02658.
    >> Share

  14. GUGLIELMI R, Mian C, Novizio R, Paoletta A, et al
    Italian guidelines for the management of adult individuals with primary hypothyroidism outside pregnancy.
    J Endocrinol Invest. 2025 Jul 23. doi: 10.1007/s40618-025-02652.
    >> Share

  15. MURA C, Fionda B, Rota CA, Pastore F, et al
    Role of Volumetric Modulated Arc radioTherapy (VMAT) in the adjuvant treatment of locally advanced differentiated thyroid cancer: single institution experience.
    J Endocrinol Invest. 2025 Jul 9. doi: 10.1007/s40618-025-02644.
    >> Share

  16. LIU SY, Wang H, Wang T, Zhou LF, et al
    METTL3 overexpression and ATF6 silencing-induced Inhibition in HAS2 expression relieves PDGF-BB stimulation-induced HA production and the proliferation of human orbital fibroblasts in graves' ophthalmopathy.
    J Endocrinol Invest. 2025 Jul 9. doi: 10.1007/s40618-025-02647.
    >> Share

  17. LIU Q, Ma B, Song M, Sun H, et al
    Causes of death among patients with metastatic differentiated thyroid cancer.
    J Endocrinol Invest. 2025 Jul 7. doi: 10.1007/s40618-025-02643.
    >> Share

  18. COMI S, Cosentino G, Sabini E, Ciampa DA, et al
    Serum levels of rapamycin predict the response of Graves' orbitopathy to sirolimus.
    J Endocrinol Invest. 2025;48:1677-1682.
    >> Share

    June 2025
  19. VANNUCCHI G, Amato C, Rotondi M, Persani L, et al
    Thyroid and female fertility: a survey on the clinical practice among endocrinologists belonging to the italian thyroid association.
    J Endocrinol Invest. 2025 Jun 30. doi: 10.1007/s40618-025-02613.
    >> Share

  20. TRIMARCHI F, Martino E, Bartalena L
    A mannequin resembling a young woman with Graves' disease.
    J Endocrinol Invest. 2025 Jun 16. doi: 10.1007/s40618-025-02628.
    >> Share

  21. MATUTINOVIC MS, Vladimirov S, Gojkovic T, Djuricic I, et al
    Analysis of non-cholesterol sterols and fatty acids in patients with graves' orbitopathy: insights into lipid metabolism in relation to the clinical phenotype of disease.
    J Endocrinol Invest. 2025;48:1333-1342.
    >> Share

    May 2025
  22. YANG C, Wei R
    From pathology to symbol: the cultural reconstruction of Thyroid Eye Disease in ancient Chinese figures-case studies of Shu King Wang Jian and General Zhang Fei.
    J Endocrinol Invest. 2025 May 28. doi: 10.1007/s40618-025-02599.
    >> Share

  23. GRAFE W, Scheibe S, Schwarz J, Liebig L, et al
    The myth of iodine: A systematic review and meta-analysis on the relationship between iodine and thyroid nodule.
    J Endocrinol Invest. 2025 May 28. doi: 10.1007/s40618-025-02606.
    >> Share

  24. PAPINI E, Basile M, Novizio R, Paoletta A, et al
    Cost analysis and resource allocation in the management of benign thyroid nodules: a comparison of surgery and thermal ablation techniques.
    J Endocrinol Invest. 2025 May 22. doi: 10.1007/s40618-025-02597.
    >> Share

  25. XU Y, Xu Z, Chen Y, Yang J, et al
    Role of thyroid function in non-basal ganglia intracerebral hemorrhage prognosis.
    J Endocrinol Invest. 2025 May 15. doi: 10.1007/s40618-025-02603.
    >> Share

  26. CHENG X, Xu S, Wu J, Gao W, et al
    Lomibuvir sensitizes radioiodine-resistant thyroid cancer cell lines to radioiodine treatment by targeting hTERT RNA-dependent polymerase activity.
    J Endocrinol Invest. 2025 May 13. doi: 10.1007/s40618-025-02598.
    >> Share

  27. MARINO PICCIOLA V, Ivaldi GP, Zamboni P
    The Fieschi conservatory of Genoa: art, medicine, and the representation of endemic goiter in 18 th-Century sculpture.
    J Endocrinol Invest. 2025 May 13. doi: 10.1007/s40618-025-02604.
    >> Share

  28. HAMMERSTAD SS, Lee HJ, Tomer Y, Stefan-Lifshitz M, et al
    Immune checkpoint inhibitors associated thyroiditis: mechanisms and clinical outcomes.
    J Endocrinol Invest. 2025 May 12. doi: 10.1007/s40618-025-02608.
    >> Share

    April 2025
  29. LIN S, Ou X, Cai L, Huang W, et al
    Efficacy and safety of Tocilizumab for thyroid eye disease: a systemic review and Meta-analysis.
    J Endocrinol Invest. 2025 Apr 30. doi: 10.1007/s40618-025-02595.
    >> Share

  30. ABDERREZAK K, Houyam A, Dana AA, Yamina A, et al
    Exposure profiles to Benzophenones and their impacts on thyroid hormones in pregnant women.
    J Endocrinol Invest. 2025 Apr 26. doi: 10.1007/s40618-025-02570.
    >> Share

  31. TRIMARCHI F, Martino E, Bartalena L
    A model with thyroid swelling portrayed by Achille Funi in the painting "maternita".
    J Endocrinol Invest. 2025 Apr 23. doi: 10.1007/s40618-025-02588.
    >> Share

  32. ZHANG D, Zhao Q, Hou S, Qu C, et al
    Coronary morphological and functional features in subclinical hypothyroidism with ST-Elevation myocardial infarction.
    J Endocrinol Invest. 2025 Apr 3. doi: 10.1007/s40618-025-02576.
    >> Share

  33. ACCORONA R, Cremasco A
    Emperor Leo I "the Thracian": a possible case of Graves' orbitopathy.
    J Endocrinol Invest. 2025;48:1057-1060.
    >> Share

    March 2025
  34. SCAPPATICCIO L, Caruso P, Di Martino N, Ferrazzano P, et al
    Correction: Thymic hyperplasia is accurate to detect new-onset Graves' hyperthyroidism and resolves after restoring euthyroidism.
    J Endocrinol Invest. 2025 Mar 25. doi: 10.1007/s40618-025-02573.
    >> Share

  35. COMI S, Cosentino G, Lanzolla G, Menconi F, et al
    Long-term outcome of Graves' orbitopathy following treatment with sirolimus.
    J Endocrinol Invest. 2025;48:607-618.
    >> Share

  36. ZHANG H, Wu J, Hu H, Tang H, et al
    UBC9: a novel therapeutic target in papillary thyroid carcinoma.
    J Endocrinol Invest. 2025 Mar 1. doi: 10.1007/s40618-024-02523.
    >> Share

    February 2025
  37. SATURNINO A, Pozzilli P, Trimarchi F
    Medical eyes on art: describing multinodular Goiter in Nicolini's Statue at the Aula Magna of University of Messina.
    J Endocrinol Invest. 2025 Feb 28. doi: 10.1007/s40618-025-02553.
    >> Share

  38. XIE Z, Liu J, Zhou J, Zhang X, et al
    MiR-27a-5p inhibits malignant progression of differentiated thyroid cancer by directly affecting the miR-27a-5p/SREBP1 axis.
    J Endocrinol Invest. 2025 Feb 13. doi: 10.1007/s40618-025-02550.
    >> Share

  39. LIVADAS S, Angelopoulos N, Kollias A, Paparodis RD, et al
    Thyroxine overuse and clinical indices guiding successful treatment withdrawal.
    J Endocrinol Invest. 2025 Feb 3. doi: 10.1007/s40618-025-02543.
    >> Share

    January 2025
  40. CHEN J, Chen Y, Huang R, Zhang P, et al
    Correction: Long noncoding RNA FAM111A-DT promotes aggressiveness of papillary thyroid cancer via activating NF-kappaB signaling.
    J Endocrinol Invest. 2025 Jan 28. doi: 10.1007/s40618-025-02538.
    >> Share

  41. RIVA MA
    Shepherd with goiter in the late-Renaissance Nativity scene of the Canonica di San Salvatore in Barzano.
    J Endocrinol Invest. 2025 Jan 27. doi: 10.1007/s40618-025-02539.
    >> Share

  42. NAPPI A, Miro C, Cicatiello AG, Sagliocchi S, et al
    The thyroid hormone activating enzyme, DIO2, is a potential pan-cancer biomarker and immunotherapy target.
    J Endocrinol Invest. 2025 Jan 17. doi: 10.1007/s40618-024-02526.
    >> Share

  43. CHEN J, Chen Y, Rong H, Zhang P, et al
    Long noncoding RNA FAM111A-DT promotes aggressiveness of papillary thyroid cancer via activating NF-kappaB signaling.
    J Endocrinol Invest. 2025 Jan 9. doi: 10.1007/s40618-025-02531.
    >> Share

    December 2024
  44. TRIMBOLI P, Colombo A, Gamarra E, Ruinelli L, et al
    Performance of computer scientists in the assessment of thyroid nodules using TIRADS lexicons.
    J Endocrinol Invest. 2024 Dec 18. doi: 10.1007/s40618-024-02518.
    >> Share

  45. DENG Y, Pan L, Xu Y, Duan Y, et al
    Aggressive variants of papillary thyroid carcinoma: characteristics, influencing factors, and effectiveness of radioiodine therapy.
    J Endocrinol Invest. 2024 Dec 9. doi: 10.1007/s40618-024-02507.
    >> Share

  46. ZHANG L, He M, Liu Y, Wang B, et al
    The immune mechanism of the mTOR/ACC1/CPT1A fatty acid oxidation signaling pathway in Hashimoto's thyroiditis.
    J Endocrinol Invest. 2024 Dec 6. doi: 10.1007/s40618-024-02501.
    >> Share

  47. PITICCHIO T, Wolde Sellasie S, D'Arrigo F, Galeano F, et al
    Clinical management of indeterminate thyroid nodules needs to be revisited. New evidence for a personalized approach to the problem.
    J Endocrinol Invest. 2024 Dec 4. doi: 10.1007/s40618-024-02510.
    >> Share

    November 2024
  48. DING H, Qin J, Li Y, Dai L, et al
    Lactoferrin alleviates oxidative stress and endoplasmic reticulum stress induced by autoimmune thyroiditis by modulating the mTOR pathway in the thyroid.
    J Endocrinol Invest. 2024 Nov 22. doi: 10.1007/s40618-024-02505.
    >> Share

  49. PAJA M, Del Cura JL, Zabala R, Korta I, et al
    A simplified four-tier classification for thyroid core needle biopsy.
    J Endocrinol Invest. 2024 Nov 22. doi: 10.1007/s40618-024-02508.
    >> Share

  50. SU Y, Mei L, Wu Y, Li C, et al
    Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of papillary thyroid carcinoma via the BRAF-ERK1/2-P53 signaling pathway.
    J Endocrinol Invest. 2024 Nov 2. doi: 10.1007/s40618-024-02481.
    >> Share

  51. CARUSO I, Di Gioia L, Di Molfetta S, Caporusso M, et al
    The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database.
    J Endocrinol Invest. 2024;47:2671-2678.
    >> Share

    October 2024
  52. SONG ZM, Wang YD, Chai F, Zhang J, et al
    Estrogen enhances the proliferation, migration, and invasion of papillary thyroid carcinoma via the ERalpha/KRT19 signaling axis.
    J Endocrinol Invest. 2024 Oct 25. doi: 10.1007/s40618-024-02473.
    >> Share

  53. PITICCHIO T, Luongo C, Trimboli P, Salvatore D, et al
    Rebound effect of hypothalamic-pituitary thyreotropic activity: a new model to better understand hypothyroidism.
    J Endocrinol Invest. 2024 Oct 21. doi: 10.1007/s40618-024-02480.
    >> Share

  54. ZHANG C, Liu A, Teng W, Yang W, et al
    Effects of acarbose and metformin on thyroid function and thyroid hormone sensitivity in type 2 diabetes patients: a post-hoc analysis of the MARCH study.
    J Endocrinol Invest. 2024 Oct 14. doi: 10.1007/s40618-024-02463.
    >> Share

  55. NERLICH AG, Perciaccante A, Bianucci R
    Severe goitre and hypothyroidism in the Austrian Biedermeier style portrait of Eleonore Feldmuller (1775-1837).
    J Endocrinol Invest. 2024 Oct 13. doi: 10.1007/s40618-024-02477.
    >> Share

  56. MENEGHINI V, Tebar WR, Santos IS, Janovsky CCPS, et al
    Thyroid peroxidase antibodies were associated with prevalent carotid intima-media thickness in middle-age and older adults: the ELSA-Brasil cohort.
    J Endocrinol Invest. 2024 Oct 9. doi: 10.1007/s40618-024-02475.
    >> Share

  57. CAMPI I, Fugazzola L
    Utility of ultra-portable ultrasound devices for the risk-stratification of thyroid dysfunctions in an emergency setting.
    J Endocrinol Invest. 2024 Oct 7. doi: 10.1007/s40618-024-02437.
    >> Share

  58. WU R, Li N, Wang X, Wang S, et al
    Mouse model of Graves' orbitopathy induced by the immunization with TSHR A and IGF-1R alpha subunit gene.
    J Endocrinol Invest. 2024;47:2507-2519.
    >> Share

  59. WANG Y, Li J, Gao S, Dang D, et al
    The role of TMEM163 protein in thyroid microcarcinoma: expression pattern and clinical implications.
    J Endocrinol Invest. 2024 Oct 1. doi: 10.1007/s40618-024-02434.
    >> Share

    September 2024
  60. VERRIENTI A, Pecce V, Grani G, Del Gatto V, et al
    Serum microRNA-146a-5p and microRNA-221-3p as potential clinical biomarkers for papillary thyroid carcinoma.
    J Endocrinol Invest. 2024 Sep 19. doi: 10.1007/s40618-024-02467.
    >> Share

  61. LE MOLI R, Naselli A, Giudice FL, Costanzo G, et al
    Temporal trends in the clinical presentation of Graves' orbitopathy: a single-center retrospective study.
    J Endocrinol Invest. 2024;47:2177-2184.
    >> Share

    August 2024
  62. PELEWICZ K, Miskiewicz P
    Glucocorticoid-induced adrenal insufficiency after therapy with intravenous methylprednisolone in patients with moderate-to-severe and active Graves' orbitopathy: assessment with a low-dose corticotropin test.
    J Endocrinol Invest. 2024;47:1987-1994.
    >> Share

  63. ZHAO YX, Wang O, Song A, Wang LJ, et al
    The risk of concurrent malignancies in patients with multiple endocrine neoplasia type 1: insights into clinical characteristics of those with multiple endocrine neoplasia type 1.
    J Endocrinol Invest. 2024;47:1931-1939.
    >> Share

    July 2024
  64. MA J, Li Z, Xu J, Lai J, et al
    PRDM1 promotes the ferroptosis and immune escape of thyroid cancer by regulating USP15-mediated SELENBP1 deubiquitination.
    J Endocrinol Invest. 2024 Jul 16. doi: 10.1007/s40618-024-02385.
    >> Share

  65. MARINO PICCIOLA V, Zamboni P, Zavagli G
    The paintings as figurative evidence of endemic goiter and cretinism in South West Piedmont in the fifteenth and sixteenth centuries.
    J Endocrinol Invest. 2024 Jul 2. doi: 10.1007/s40618-024-02424.
    >> Share

  66. ALBERTELLI M, Rossi G, Nazzari E, Genova C, et al
    Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study.
    J Endocrinol Invest. 2024;47:1805-1814.
    >> Share

  67. SOUBRY E, David K, Swillen A, Vergaelen E, et al
    Endocrine manifestations in adults with 22q11.2 deletion syndrome: a retrospective single-center cohort study.
    J Endocrinol Invest. 2024;47:1827-1836.
    >> Share

  68. COMI S, Lanzolla G, Cosentino G, Maglionico MN, et al
    IgG4 serum levels in Graves' orbitopathy.
    J Endocrinol Invest. 2024;47:1711-1717.
    >> Share

    June 2024
  69. ZAVAGLI G, Marino Picciola V, Zamboni P
    Sculptures with goiter in the Ossuccio Sacred Mount: when pathognomonic signs have a specific moral significance.
    J Endocrinol Invest. 2024 Jun 26. doi: 10.1007/s40618-024-02423.
    >> Share

  70. ZHOU YY, Zhao SY, Huang FJ, Zhang LJ, et al
    JPT2 in subclinical hypothyroidism-related miscarriage as a transcription co-factor: involvement of LEPR/STAT3 activation.
    J Endocrinol Invest. 2024 Jun 22. doi: 10.1007/s40618-024-02343.
    >> Share

  71. COPERCHINI F, Greco A, Petrosino E, Croce L, et al
    Selective anti-CXCR2 receptor blockade by AZD5069 inhibits CXCL8-mediated pro-tumorigenic activity in human thyroid cancer cells in vitro.
    J Endocrinol Invest. 2024 Jun 20. doi: 10.1007/s40618-024-02410.
    >> Share

  72. GALOFRE JC, Diez JJ, Attanasio R, Nagy EV, et al
    Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration.
    J Endocrinol Invest. 2024 Jun 15. doi: 10.1007/s40618-024-02409.
    >> Share

  73. BENELLI E, Marradi M, Sciarroni E, Di Cosmo C, et al
    Thyroid autoimmunity in different phenotypes of polycystic ovary syndrome: a single-center experience.
    J Endocrinol Invest. 2024 Jun 8. doi: 10.1007/s40618-024-02404.
    >> Share

  74. BIANUCCI R, Perciaccante A, Nerlich AG
    The laywoman church builder Lucrezia Agliarti Vertova (ca 1484-March 24th 1557) had endemic goitre.
    J Endocrinol Invest. 2024;47:1583-1584.
    >> Share

    May 2024
  75. XIAO R, Wang Q, Ni C, Pan W, et al
    Interplay of metabolic dysfunction-associated fatty liver disease and papillary thyroid carcinoma: insights from a Chinese cohort.
    J Endocrinol Invest. 2024 May 24. doi: 10.1007/s40618-024-02391.
    >> Share

  76. BOROWCZYK M, Kaczmarek-Rys M, Hryhorowicz S, Sypniewski M, et al
    Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment.
    J Endocrinol Invest. 2024 May 16. doi: 10.1007/s40618-024-02389.
    >> Share

  77. ZENG C, Zhang Y, Lin C, Liang W, et al
    TFCP2L1, a potential differentiation regulator, predicts favorable prognosis and dampens thyroid cancer progression.
    J Endocrinol Invest. 2024 May 16. doi: 10.1007/s40618-024-02392.
    >> Share

  78. LU J, Liu X, Cen A, Hong Y, et al
    HYPOXIA induces lncRNA HOTAIR for recruiting RELA in papillary thyroid cancer cells to upregulate miR-181a and promote angiogenesis.
    J Endocrinol Invest. 2024 May 15. doi: 10.1007/s40618-024-02388.
    >> Share

  79. OTERI V, Piane S, Cocci E
    The use of telecytology for the evaluation of thyroid nodules fine-needle aspiration biopsy specimens: a systematic review.
    J Endocrinol Invest. 2024 May 4. doi: 10.1007/s40618-024-02378.
    >> Share

  80. HEYDARZADEH S, Moshtaghie AA, Daneshpour M, Hedayati M, et al
    Regulation of iodine-glucose flip-flop in SW1736 anaplastic thyroid cancer cell line.
    J Endocrinol Invest. 2024 May 2. doi: 10.1007/s40618-024-02377.
    >> Share

    April 2024
  81. STRAMAZZO I, Mangino G, Capriello S, Romeo G, et al
    CD20 + T lymphocytes in isolated Hashimoto's thyroiditis and type 3 autoimmune polyendocrine syndrome: a pilot study.
    J Endocrinol Invest. 2024 Apr 20. doi: 10.1007/s40618-024-02370.
    >> Share

  82. SCHUBERT L, Mbekwe-Yepnang AM, Wassermann J, Braik-Djellas Y, et al
    Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status.
    J Endocrinol Invest. 2024 Apr 5. doi: 10.1007/s40618-024-02352.
    >> Share

    March 2024
  83. SCAPPATICCIO L, Caruso P, Di Martino N, Ferrazzano P, et al
    Thymic hyperplasia is accurate to detect new-onset Graves' hyperthyroidism and resolves after restoring euthyroidism.
    J Endocrinol Invest. 2024 Mar 30. doi: 10.1007/s40618-024-02355.
    >> Share

  84. OZER Y, Anik A, Sayili U, Tercan U, et al
    High frequency of transient congenital hypothyroidism among infants referred for suspected congenital hypothyroidism from the Turkish National screening program: thyroxine dose may guide the prediction of transients.
    J Endocrinol Invest. 2024 Mar 28. doi: 10.1007/s40618-024-02348.
    >> Share

  85. JANSEN HI, Heuveling van Beek C, Bisschop PH, Heijboer AC, et al
    The need for the GREAT+ score to predict relapse in Graves' disease: a questionnaire among patients and internal medicine specialists.
    J Endocrinol Invest. 2024 Mar 25. doi: 10.1007/s40618-024-02358.
    >> Share

  86. COPERCHINI F, Greco A, Rotondi M
    Changing the structure of PFOA and PFOS: a chemical industry strategy or a solution to avoid thyroid-disrupting effects?
    J Endocrinol Invest. 2024 Mar 24. doi: 10.1007/s40618-024-02339.
    >> Share

  87. MENOTTI S, Mura C, Raia S, Bergianti L, et al
    Overt hypothyroidism in pregnancy and language development in offspring: is there an association?
    J Endocrinol Invest. 2024 Mar 18. doi: 10.1007/s40618-024-02317.
    >> Share

  88. WANG C, Wang Z, Fu L, Du J, et al
    CircNRCAM up-regulates NRCAM to promote papillary thyroid carcinoma progression.
    J Endocrinol Invest. 2024 Mar 14. doi: 10.1007/s40618-023-02241.
    >> Share

  89. D'ANIELLO F, Amodeo ME, Grossi A, Ubertini G, et al
    Thyroiditis and COVID-19: focus on pediatric age. A narrative review.
    J Endocrinol Invest. 2024 Mar 8. doi: 10.1007/s40618-024-02331.
    >> Share

  90. SPARANO C, Puccioni M, Adornato V, Zago E, et al
    Improving the TIR3B oncological stratification: try to bridge the gap through a comprehensive presurgical algorithm.
    J Endocrinol Invest. 2024;47:633-643.
    >> Share

    February 2024
  91. ZHANG GQ, Xi C, Ju NT, Shen CT, et al
    Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer.
    J Endocrinol Invest. 2024 Feb 22. doi: 10.1007/s40618-023-02294.
    >> Share

  92. BABAYID Y, Gokcay Canpolat A, Elhan AH, Ceyhan K, et al
    Should there be a paradigm shift for the evaluation of isthmic thyroid nodules?
    J Endocrinol Invest. 2024 Feb 16. doi: 10.1007/s40618-024-02313.
    >> Share

  93. LIU L, Cai S, Chen A, Dong Y, et al
    Long-term prognostic value of thyroid hormones in left ventricular noncompaction.
    J Endocrinol Invest. 2024 Feb 15. doi: 10.1007/s40618-024-02311.
    >> Share

  94. EVRANOS BO, Ince N, Atas H, Polat SB, et al
    Successful localisation of recurrent thyroid cancer using preoperative patent blue dye injection.
    J Endocrinol Invest. 2024 Feb 14. doi: 10.1007/s40618-024-02301.
    >> Share

  95. CENSI S, Carducci S, Zoppini G, Toffalini A, et al
    Calcitonin levels in autoimmune atrophic gastritis-related hypergastrinemia.
    J Endocrinol Invest. 2024;47:357-365.
    >> Share

    January 2024
  96. HE C, Li Y, Gan L, Lin Y, et al
    Notch signaling regulates Th17 cells differentiation through PI3K/AKT/mTORC1 pathway and involves in the thyroid injury of autoimmune thyroiditis.
    J Endocrinol Invest. 2024 Jan 29. doi: 10.1007/s40618-023-02293.
    >> Share

  97. KENARLI K, Bahcecioglu AB, Aksu OB, Gullu S, et al
    Are sonographic characteristics of Hashimoto's thyroiditis related with immunologic parameters? A cross-sectional study.
    J Endocrinol Invest. 2024 Jan 21. doi: 10.1007/s40618-023-02286.
    >> Share

  98. LOSA M, Albano L, Barzaghi LR, Bailo M, et al
    Gamma knife radiosurgery is effective in patients with thyrotropin-secreting pituitary adenomas.
    J Endocrinol Invest. 2024 Jan 20. doi: 10.1007/s40618-023-02291.
    >> Share

  99. TAGGI M, Capponi C, Bertani N, Saturno G, et al
    Role of thyroid stimulating hormone in the maintenance and functioning of the human corpus luteum.
    J Endocrinol Invest. 2024 Jan 8. doi: 10.1007/s40618-023-02269.
    >> Share

  100. COSENTINO G, Comi S, Maglionico MN, Marino M, et al
    A case of carotid cavernous fistula mimicking Graves' orbitopathy.
    J Endocrinol Invest. 2024;47:255-256.
    >> Share

    December 2023
  101. LU DN, Zhang WC, Lin YZ, Jiang HY, et al
    Single-cell and bulk RNA sequencing reveal heterogeneity and diagnostic markers in papillary thyroid carcinoma lymph-node metastasis.
    J Endocrinol Invest. 2023 Dec 26. doi: 10.1007/s40618-023-02262.
    >> Share

  102. GONG Z, Xue L, Vlantis AC, van Hasselt CA, et al
    Brusatol attenuated proliferation and invasion induced by KRAS in differentiated thyroid cancer through inhibiting Nrf2.
    J Endocrinol Invest. 2023 Dec 7. doi: 10.1007/s40618-023-02248.
    >> Share

    November 2023
  103. PRETE A, Pieroni E, Marrama E, Bruschini L, et al
    Management of patients with extensive locally advanced thyroid cancer: results of multimodal treatments.
    J Endocrinol Invest. 2023 Nov 30. doi: 10.1007/s40618-023-02234.
    >> Share

  104. FELDT-RASMUSSEN U, Effraimidis G, Bliddal S, Klose M, et al
    Risks of suboptimal and excessive thyroid hormone replacement across ages.
    J Endocrinol Invest. 2023 Nov 28. doi: 10.1007/s40618-023-02229.
    >> Share

  105. BEDULEVA L, Sidorov A, Fomina K, Terentiev A, et al
    Experimental rat models for Hashimoto's thyroiditis.
    J Endocrinol Invest. 2023 Nov 27. doi: 10.1007/s40618-023-02240.
    >> Share

    October 2023
  106. LEI C, Qu M, Sun H, Huang J, et al
    Facial expression of patients with Graves' orbitopathy.
    J Endocrinol Invest. 2023;46:2055-2066.
    >> Share

  107. CAO J, Qi X, Wang N, Chen Y, et al
    Ceruloplasmin regulating fibrosis in orbital fibroblasts provides a novel therapeutic target for Graves' orbitopathy.
    J Endocrinol Invest. 2023;46:2005-2016.
    >> Share

    September 2023
  108. CAPPELLANI D, Bartalena L, Bogazzi F
    Short review: novel concepts in the approach to patients with amiodarone-induced thyrotoxicosis.
    J Endocrinol Invest. 2023 Sep 20. doi: 10.1007/s40618-023-02168.
    >> Share

  109. CROCE L, Ruggeri RM, Cappelli C, Virili C, et al
    Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis.
    J Endocrinol Invest. 2023 Sep 13. doi: 10.1007/s40618-023-02191.
    >> Share

    August 2023
  110. BESHARAT ZM, Trocchianesi S, Verrienti A, Ciampi R, et al
    Correction: Circulating miR‑26b‑5p and miR‑451a as diagnostic biomarkers in medullary thyroid carcinoma patients.
    J Endocrinol Invest. 2023 Aug 10. doi: 10.1007/s40618-023-02172.
    >> Share

  111. ZHANG H, Xie H, Li L
    Association of radioactive iodine treatment in differentiated thyroid cancer and cardiovascular death: a large population-based study.
    J Endocrinol Invest. 2023 Aug 6. doi: 10.1007/s40618-023-02159.
    >> Share

  112. LANZOLLA G, Di Matteo L, Comi S, Cosentino G, et al
    Absence of a relationship between vitamin D and Graves' orbitopathy.
    J Endocrinol Invest. 2023;46:1717-1721.
    >> Share

    July 2023
  113. JIANG C, Xu F, Yi D, Jiang B, et al
    Testosterone promotes the migration, invasion and EMT process of papillary thyroid carcinoma by up-regulating Tnnt1.
    J Endocrinol Invest. 2023 Jul 21. doi: 10.1007/s40618-023-02132.
    >> Share

  114. WUSIMAN D, Guo L, Li L, Zhang X, et al
    Clinicopathological and prognostic significance of PD-L1 and TIM-3 expression in medullary thyroid carcinoma: a retrospective immunohistochemistry study.
    J Endocrinol Invest. 2023 Jul 18. doi: 10.1007/s40618-023-02126.
    >> Share

  115. PELEWICZ-SOWA M, Miskiewicz P
    Dysthyroid optic neuropathy: emerging treatment strategies.
    J Endocrinol Invest. 2023;46:1305-1316.
    >> Share

    June 2023
  116. MA Q, Chen Z, Fang Y, Wei X, et al
    Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
    J Endocrinol Invest. 2023 Jun 9. doi: 10.1007/s40618-023-02129.
    >> Share

  117. BESHARAT ZM, Trocchianesi S, Verrienti A, Ciampi R, et al
    Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients.
    J Endocrinol Invest. 2023 Jun 7. doi: 10.1007/s40618-023-02115.
    >> Share

    May 2023
  118. ASHRAFIAN H
    Goiter in the paintings by Rogier van der Weyden (1399-1464).
    J Endocrinol Invest. 2023 May 12. doi: 10.1007/s40618-023-02108.
    >> Share

  119. ASHRAFIAN H
    Goiter, thyroid facial involvement and eye disease in the paintings of Jan Gossaert (c. 1478-1532).
    J Endocrinol Invest. 2023 May 6. doi: 10.1007/s40618-023-02104.
    >> Share

  120. JIANG B, Wang C, Qu C, Jiang C, et al
    Primary human thyrocytes maintained the function of thyroid hormone production and secretion in vitro.
    J Endocrinol Invest. 2023 May 3. doi: 10.1007/s40618-023-02103.
    >> Share

  121. BIANUCCI R, Galassi FM, Donell ST, Nerlich AG, et al
    Goitre in a Fayum mummy portrait from Roman Egypt (120-140 CE).
    J Endocrinol Invest. 2023;46:1041-1042.
    >> Share

    April 2023
  122. BERLINSKA A, Swiatkowska-Stodulska R
    Simple nontoxic goiter in the portrayal of Saints: a magnificent representation in one piece of art.
    J Endocrinol Invest. 2023 Apr 28. doi: 10.1007/s40618-023-02097.
    >> Share

  123. DORIZZI RM, Spiazzi G, Rolli N, Maltoni P, et al
    Trimester-specific reference intervals for thyroid function parameters in pregnant Caucasian women using Roche platforms: a prospective study.
    J Endocrinol Invest. 2023 Apr 24. doi: 10.1007/s40618-023-02098.
    >> Share

  124. LORUSSO L, Minaldi E, Esposito G, Piaggi P, et al
    Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features.
    J Endocrinol Invest. 2023 Apr 21. doi: 10.1007/s40618-023-02076.
    >> Share

  125. RUGGERI RM, Spagnolo CC, Alibrandi A, Silvestris N, et al
    Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center.
    J Endocrinol Invest. 2023 Apr 20. doi: 10.1007/s40618-023-02096.
    >> Share

  126. GRANI G, Lamartina L, Montesano T, Maranghi M, et al
    Ultrasound screening for thyroid nodules and cancer in individuals with family history of thyroid cancer: a micro-costing approach.
    J Endocrinol Invest. 2023 Apr 13. doi: 10.1007/s40618-023-02087.
    >> Share

  127. PERONA M, Ibanez IL, Thomasz L, Villaverde MS, et al
    Valproic acid radiosensitizes anaplastic thyroid cells through a decrease of the DNA damage repair capacity.
    J Endocrinol Invest. 2023 Apr 13. doi: 10.1007/s40618-023-02092.
    >> Share

  128. CALCATERRA V, Gazzarri A, De Silvestri A, Madia C, et al
    Thyroid function, sensitivity to thyroid hormones, and metabolic syndrome in euthyroid children and adolescents with Down syndrome.
    J Endocrinol Invest. 2023 Apr 11. doi: 10.1007/s40618-023-02086.
    >> Share

  129. PINTO S, Croce L, Carlier L, Cosson E, et al
    Thyroid dysfunction during gestation and gestational diabetes mellitus: a complex relationship.
    J Endocrinol Invest. 2023 Apr 7. doi: 10.1007/s40618-023-02079.
    >> Share

  130. SARIC MATUTINOVIC M, Kahaly GJ, Zarkovic M, Ciric J, et al
    The phenotype of Graves' orbitopathy is associated with thyrotropin receptor antibody levels.
    J Endocrinol Invest. 2023 Apr 5. doi: 10.1007/s40618-023-02085.
    >> Share

  131. SIGMAN B, Linder DF, Waller JL, Bollag WB, et al
    Hashimoto's thyroiditis and renal transplant rejection.
    J Endocrinol Invest. 2023 Apr 4. doi: 10.1007/s40618-023-02065.
    >> Share

  132. COSENTINO G, Comi S, Coco B, Marino M, et al
    Autoimmune hepatitis after high-dose intravenous glucocorticoids for Graves' orbitopathy.
    J Endocrinol Invest. 2023;46:849-850.
    >> Share

  133. BETTERLE C, Furmaniak J, Sabbadin C, Scaroni C, et al
    Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy.
    J Endocrinol Invest. 2023;46:643-665.
    >> Share

  134. MODICA R, Benevento E, Colao A
    Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship.
    J Endocrinol Invest. 2023;46:667-677.
    >> Share

  135. LI YY, Li SJ, Liu MC, Chen Z, et al
    B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer.
    J Endocrinol Invest. 2023 Apr 1. doi: 10.1007/s40618-023-02072.
    >> Share

    March 2023
  136. PATTI L, Gay S, Musso L, Maltese C, et al
    Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis.
    J Endocrinol Invest. 2023 Mar 28. doi: 10.1007/s40618-023-02070.
    >> Share

  137. BAGALA V, Sala A, Trevisan C, Okoye C, et al
    Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study.
    J Endocrinol Invest. 2023 Mar 27:1-9. doi: 10.1007/s40618-023-02048.
    >> Share

  138. PECCE V, Sponziello M, Verrienti A, Grani G, et al
    The role of miR-139-5p in radioiodine-resistant thyroid cancer.
    J Endocrinol Invest. 2023 Mar 18. doi: 10.1007/s40618-023-02059.
    >> Share

  139. MONTI E, Gay S, Dono M, Giusti M, et al
    PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience.
    J Endocrinol Invest. 2023 Mar 18. doi: 10.1007/s40618-023-02063.
    >> Share

  140. FELICETTI F, Gatti F, Faraci D, Rosso D, et al
    Impact of allogeneic stem cell transplantation on thyroid function.
    J Endocrinol Invest. 2023 Mar 8. doi: 10.1007/s40618-023-02039.
    >> Share

    February 2023
  141. BRANCATELLA A, Torregrossa L, Viola N, Sgro D, et al
    In Graves' disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features.
    J Endocrinol Invest. 2023 Feb 25. doi: 10.1007/s40618-023-02044.
    >> Share

  142. DI SESSA A, Cembalo Sambiase Sanseverino N, De Simone RF, Marrapodi MM, et al
    Association between non-alcoholic fatty liver disease and subclinical hypothyroidism in children with obesity.
    J Endocrinol Invest. 2023 Feb 24. doi: 10.1007/s40618-023-02041.
    >> Share

    March 2021
  143. TRIMARCHI F, Martino E, Bartalena L
    The Virgin Mary with a small goiter breastfeeding the Child.
    J Endocrinol Invest. 2021;44:641-642.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016